Bone marrow fibroblasts in patients with advanced lung cancer

In a previous study we demonstrated that the incidence of fibroblast colony-forming units (CFU-F) was very low in bone marrow primary cultures from the majority of untreated advanced non-small lung cancer patients (LCP) compared to normal controls (NC). For this reason, we studied the ability of bon...

Descripción completa

Guardado en:

Detalles Bibliográficos
Publicado:	2001
Materias:	Cancer Fibroblasts Interleukin-1 Prostaglandin E2 interleukin 1beta prostaglandin E2 adult advanced cancer article bone marrow cell bone marrow culture cancer patient cell assay cell proliferation clinical article colony forming unit F controlled study culture medium cytokine production enzyme linked immunosorbent assay fibroblast fibroblast culture human human cell lung cancer lung non small cell cancer prostaglandin synthesis radioimmunoassay stroma cell
Acceso en línea:	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0100879X_v34_n11_p1457_Chasseing http://hdl.handle.net/20.500.12110/paper_0100879X_v34_n11_p1457_Chasseing
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Bone marrow fibroblasts in patients with advanced lung cancer
por: Chasseing, N.A., et al.

Bone marrow fibroblastic progenitors in patients with advanced breast cancer
Publicado: (1997)

Bone marrow fibroblastic progenitors in patients with advanced breast cancer
por: Chasseing, N.A., et al.

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients
Publicado: (2002)

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients
por: Honegger, A.E., et al.

Fibroblastic colony-forming units and levels of tumor necrosis factor and prostaglandin E2 in bone marrow cultures from patients with advanced lung carcinoma
Publicado: (1997)

Fibroblastic colony-forming units and levels of tumor necrosis factor and prostaglandin E2 in bone marrow cultures from patients with advanced lung carcinoma
por: Chasseing, N.A., et al.

Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow
Publicado: (2010)

Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow
por: Hofer, E.L., et al.

Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis
Publicado: (2013)

Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis
por: Fernández Vallone, V.B., et al.

In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
Publicado: (2001)

In vitro secretion of cytokines and prostaglandin-E2 by monocytes from lung cancer patients
por: Trejo, Y.G., et al.

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
Publicado: (2005)

Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients
por: Hofer, E.L., et al.

Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
Publicado: (2014)

Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
por: Martinez, L.M., et al.

Tumor necrosis factor-alfa production by monocytes from lung and colorectal cancer patients
Publicado: (2001)

Tumor necrosis factor-alfa production by monocytes from lung and colorectal cancer patients
por: Trejo, Y.G., et al.

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
Publicado: (2008)

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
por: Giulianelli, S., et al.

Ag-NOR staining and satellite association in bone marrow cells from patients with mycosis fungoides
por: Pedrazzini, Estela Maris, et al.
Publicado: (1995)

The inhibitory action of aluminum on mouse bone marrow cell growth: Evidence for an erythropoietin- and transferrin-mediated mechanism
Publicado: (1994)

The inhibitory action of aluminum on mouse bone marrow cell growth: Evidence for an erythropoietin- and transferrin-mediated mechanism
por: Garbossa, G., et al.

Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients
Publicado: (2002)

Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients
por: De Cavanagh, E.M.V., et al.

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
Publicado: (2018)

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
por: Elola, M.T., et al.

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
Publicado: (2014)

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
por: Wan, X., et al.

αtransforming growth factorlike activities and bifunctional regulators of cell growth in human malignant neoplasms
Publicado: (1990)

αtransforming growth factorlike activities and bifunctional regulators of cell growth in human malignant neoplasms
por: Elizalde, P.V., et al.

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
Publicado: (2012)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, V., et al.

Ploidy in Bone-Marrow Cells from Healthy Donors - A Mac (Morphology Antibody Chromosomes) Study
por: Larramendy, Marcelo Luis, et al.
Publicado: (1994)

Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
por: Puricelli, Lydia Inés, et al.
Publicado: (2010)

Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
por: Carlini, M.J., et al.

Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
por: Degese, Maria Sol, et al.
Publicado: (2012)

Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
por: Degese, M.S., et al.

Esperanza como Factor Protector de Crecimiento Postraumático en Pacientes con Trasplante Médula Ósea
por: Valentini, Aurora Beatriz, et al.
Publicado: (2017)